As such we analyzed interacting compound predictions of DRUIDom for PI3K/AKT/mTOR pathway proteins, out of which, we focused on LIMK1 and LIMK2 proteins and their new ligand predictions, as these proteins have been associated with several types of cancer especially in terms of progression and metastasis [30–33]. Here, LIMK2 is linked to cancer.